Drugs / Anti-pandemic H1N1 influenza vaccine
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT01151644 Comparator | Apr → Jul 2010 | Sjogren syndrome, antiphospholipid syndrome, juvenile dermatomyositis, juvenile idiopathic arthritis +6 | University of Sao Paulo | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Anti-pandemic H1N1 influenza vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01151644 ↗ |
| Modality | Vaccine | “inactivated, NON-adjuvanted pandemic H1N1 influenza vaccine (A/California/7/2009)” NCT01151644 ↗ |